Cargando…
Single-cell transcriptomics of peripheral blood reveals anti-tumor systemic immunity induced by oncolytic virotherapy
Rationale: Oncolytic virus (OV) therapy as a cancer therapy that improves immune status makes it a favorable candidate for optimizing immunotherapy strategies. Existing studies have focused on characterizing the disturbance of the tumor microenvironment (TME) by OV therapy. However, the changes in s...
Autores principales: | Wu, Quanyou, Hu, Xiao, Zhang, Xiaoli, Kong, Defeng, Yang, Zhenrong, Li, Guoliang, Gu, Zhaoru, Zhang, Qi, Wan, Duo, Cheng, Shujun, Liu, Binlei, Zhang, Kaitai, Zhang, Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691353/ https://www.ncbi.nlm.nih.gov/pubmed/36438484 http://dx.doi.org/10.7150/thno.74075 |
Ejemplares similares
-
SIRPα antibody combined with oncolytic virus OH2 protects against tumours by activating innate immunity and reprogramming the tumour immune microenvironment
por: Kong, Defeng, et al.
Publicado: (2022) -
Establishment of gastric signet ring cell carcinoma organoid for the therapeutic drug testing
por: Li, Guoliang, et al.
Publicado: (2022) -
Telomerase positive CTCs with PSMA high expression associated with prostate cancer metastasis
por: Yang, Zhenrong, et al.
Publicado: (2022) -
Enhanced Therapeutic Efficacy of a Novel Oncolytic Herpes Simplex Virus Type 2 Encoding an Antibody Against Programmed Cell Death 1
por: Zhu, Yujie, et al.
Publicado: (2019) -
ONCOLYTIC VIROTHERAPY
por: Russell, Stephen J, et al.
Publicado: (2012)